CRID has reached 10,000 identifiers!
Representing individuals and families across hundreds of rare diseases worldwide. Thank you to everyone who has supported this journey. https://t.co/w09X4uQVFi
#RareDisease#CRID#CLIRINX#Research#Genetics#Epilepsy#Liver
It's concerning when I see companies mass collecting patient data through so called "surveys" and "patient engagement" with minimal to no governance or ethical oversight, usually with a misleading or deceptive description.
#EthicalPatientResearch#StopPatientDataHarvesting
Big step forward for PBC Ireland.
Real-world data. Patient voice. Global impact. A first for patient-led research in Ireland.
#PBC#RareDisease#Innovation#CPath#PatientVoice
https://t.co/8kYdATVfNo
📣 Major Announcement for PBC Ireland 📣
Our first academic paper emerging from the PBC Ireland Patient Registry has now been accepted for publication in the peer-reviewed journal Therapeutic Advances in Rare Diseases. This is a first for the PBC community in Ireland.
Too many people with PBC say clinic visits feel rushed and focused only on blood tests, leaving symptoms like fatigue, itch, and quality of life unheard...
🍀 PBC Awareness Day -- Sept 14th, 2025 -- Lá Feasachta PBC 🍀
PBC Ireland is here to support, connect, and advocate for everyone living with Primary Biliary Cholangitis in Ireland. https://t.co/k1xLFc1IR6
PBC Ireland has received full ethics approval from the IRB for our new patient registry. This marks a major milestone in our efforts to gather real-world data, support research and improve the lives of people living with PBC in Ireland. More to come! #PBC#PatientRegistry#Rare
CRID is the most patient-centric UPI system in research today. It bypasses regulatory complexity by staying out of clinical care and staying inside research domains.
It enables ethical reuse of existing patient data and biospecimens and works in all rare disease networks.
CLIRINX delivers the world's most advanced patient-led registry for Primary Biliary Cholangitis (PBC). Developed with @PBCIreland, it sets a new standard for how rare disease data is collected, owned and used by patients, for patients. #PBC#PatientLed#PatientRegistry@_TheCRID
We’ve released the Automatic CRID Creation API, making it easier for 3rd party applications to generate Clinical Research IDs (CRIDs) directly from within their systems.
This is a big step toward improving data linkage across research studies #CRID#NoMoreDataSilos#RareDiseases
If you're a rare disease org or academic researcher using the CRID and your IRB needs support in determining if CRID is PHI or not, please contact us to get our statement, “Why the CRID Is Not PHI and Should Be Allowed in De-identified Research Datasets,” to assist in your IRB
The University of Melbourne has recently launched what may become the largest genetic epilepsy natural history study ever conducted, powered by the CLIRINX system! #RareDiseases#NaturalHistoryStudy#Genetics#Epilepsy
After 12 years focusing on the US rare disease market, CLIRINX is expanding in Ireland & the EU. We've deployed AWS infrastructure in Dublin to support local patient registries, natural history studies & clinical trial readiness. #RareDiseases#Ireland#GDPR